T3 WEBINAR: HCV NAT+/- in Thoracic Organ Transplantation: Where Are We Now and What's Next?
May 20, 2020 from 02:00pm to 03:00pm EDT
2019-2020 Timely Topics in Trasplantation (T3) Webinar
Kelly Schlendorf, MD, MHS • Assistant Professor of Medicine, Vanderbilt Heart and Vascular Institute, Nashville, TN
Marcelo Cypel MD, MSc, FACS, FRCSC • Associate Professor of Surgery, University of Toronto (UHN), Toronto, ON
Daniel Kaul, MD • Professor of Internal Medicine, University of Michigan, Ann Arbor, MI
After participating in this webinar, the attendee will be able to:
- Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for heart transplantation
- Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for lung transplantation
- Describe future directions for utilization of HCV donors (NAT+/-) for thoracic organ transplantation
AST would like to thank the Infectious Disease (IDCOP), Kidney Pancreas (KPCOP), and Liver and Intestinal (LICOP) Communities of Practice for each recommending "HCV" as a topic for the 2019-2020 T3 series. The concept was expanded into two HCV NAT+/- sessions, one covering "HCV NAT+/- in Abdominal Organ Transplantation" and another covering "HCV NAT+/- in Thoracic Organ Transplantation."